secwatch.observer — SEC 8-K summary
======================================

Issuer:     EDAP TMS SA (EDAP)
CIK:        0001041934
Form:       8-K
Filed at:   2026-08-13T20:02:17+00:00
Accession:  0001171843-26-005498
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FocalTherics Q2 revenue up 39% to $13.2M; net loss widens; $40M offering
------------------------------------------------------------------------

- Revenue $13.2M, +39% YoY; U.S. procedure volume +47%; 13 Focal One systems sold vs 9.
- Gross margin 55.6% vs 51.1%; operating loss $8.0M vs $6.6M; net loss $14.4M ($0.38/sh) vs $6.4M.
- ESWL and Distribution reclassified as discontinued operations; HIFU now only continuing ops; cash $21.5M.
- FY2026 revenue guidance reaffirmed $50-54M (34-45% growth); $40M public offering expected to close Aug 14.
- Launched first commercial Focal One Endometriosis program in Europe; installed base 184 (96 U.S.).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1041934/000117184326005498/0001171843-26-005498-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1041934/000117184326005498/f8k_081326.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-005498

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer